Pharmacological differentiation of kainate receptors on neonatal rat spinal motoneurones and dorsal roots

Neuropharmacology

Volumn 37, Issue 10-11, 1998, Pages 1223-1237

  Thomas, Nicola K ^a   Hawkins, Lynda M ^b   Miller, Jacqueline C ^a   Troop, Helen M ^a   Roberts, Peter J ^a   Jane, David E ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

(RS) 2 Amino 3 (5 t butyl 3 hydroxyisoxazol 4 yl)propanoic acid (ATPA); (RS) 3,4 Dicarboxyphenylglycine (3,4 DCPG); (RS) 3,5 Dicarboxyphenylglycine (3,5 DCPG); GYKI53655; Neonatal rat spinal cord; Willardiine analogues

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 5 PHOSPHONOVALERIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CYCLOTHIAZIDE; GLYCINE DERIVATIVE; KAINIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; PROPIONIC ACID DERIVATIVE; WILLARDIINE;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DEPOLARIZATION; DORSAL ROOT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD MOTONEURON;

ALANINE; ANIMALS; ANIMALS, NEWBORN; BENZOATES; EXCITATORY AMINO ACID AGONISTS; GLYCINE; MOTOR NEURONS; PYRIMIDINONES; RATS; RECEPTORS, KAINIC ACID; SPINAL CORD; SPINAL NERVE ROOTS; URACIL;

EID: 0032192103     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00124-5     Document Type: Conference Paper

References (29)

1. Agrawal, S.G., Evans, R.H., 1986. The primary afferent depolarizing action of kainate in the rat. British Journal of Pharmacology 87, 345-355.
2. Bettler, B., Boulter, J., Hermans-Borgmeyer, L, et al., 1990. Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron 5, 583-595.
3. Bettler, B., Mulle, C., 1995. Neurotransmitter receptors. 2. AMPA and kainate receptors. Neuropharmacology 34, 123-139.
4. Bigge, C.F., Boxer, P.A., Ortwine, D.F., 1996. AMPA/kainate receptors. Current Pharmaceutical Design 2, 397-412.
5. Blake, J.F., Jane, D.E., Watkins, J.C., 1991. Action of willardiine analogs on immature rat dorsal roots. British Journal of Pharmacology 104, 334P.
6. Bleakman, D., Ballyk, B.A., Schoepp, D.D., et al., 1996a. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology 35, 1689-1702.
7. Bleakman, D., Schoepp, D.D., Ballyk, B., et al., 1996b. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S;4aR,6R,8aR)-6-[2-(1(2H)-tetrazole-5-yl)ethyl]decahydro-isoquinoline-3-carboxylic acid. Molecular Pharmacology 49, 581-585.
8. Clarke, V.R., Ballyk, B.A., Hoo, K.H., et al., 1997. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389, 599-603.
9. Conn, P.J., Pin, J.P., 1997. Pharmacology and functions of metabotropic glutamate receptors. Annual Review of Pharmacology and Toxicology 37, 205-237.
10. Ebert, B., Madsen, U., Søby, K.K., Krogsgaard-Larsen, P., 1996. Functional partial agonism at ionotropic excitatory amino acid receptors. Neurochemistry International 29, 309-316.
11. Evans, R.H., Francis, A.A., Jones, A.W., Smith, D.A.S., Watkins, J.C., 1982. The effects of a series of ω-phosphonic α-carboxylic amino acids on electrically evoked and amino acid induced responses in isolated spinal cord preparations. British Journal of Pharmacology 75, 65-75.
12. Fletcher, E.J., Lodge, D., 1996. New developments in the molecular pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors. Pharmacology and Therapeutics 70, 65-89.
13. Jane, D.E., Pook, P.C.K., Sunter, D.C., Udvarhelyi, P.M., Watkins, J.C., 1991. New willardiine analogs with potent stereoselective actions on mammalian spinal neurones. British Journal of Pharmacology 104, 333P.
14. Jane, D.E., Olverman, H.J., Watkins, J.C., 1994. Agonists and competitive antagonists: structure-activity and molecular modelling studies. In: Collingridge, G.L., Watkins, J.C. (Eds.), The NMDA Receptor, 2. Oxford University, Oxford.
15. Jane, D.E., Hoo, K., Kamboj, R., Deverill, M., Bleakman, D., Mandlezys, A., 1997. Synthesis of willardiine and 6-azawillardiine analogues: Pharmacological characterisation on cloned homomeric human AMPA and kainate receptor subtypes. Journal of Medicinal Chemistry 40, 3645-3650.
16. Jones, K.A., Wilding, T.J., Heuttner, J.E., Costa, A.M., 1997. Desensitisation of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate. Neuropharmacology 36, 853-863.
17. Matzen, L., Engesgaard, A., Ebert, B., Didriksen, M., Fralund, B., Krogsgaard-Larsen, P., Jaroszewski, J.W., 1997. AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid. Journal of Medicinal Chemistry 40, 520-527.
18. Partin, K.M., Patneau, D.K., Winters, C.A., Mayer, M.L., Buonanno, A., 1993. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11, 1069-1082.
19. Patneau, D.K., Mayer, M.L., Jane, D.E., Watkins, J.C., 1992. Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine. Journal of Neuroscience 12, 595-606.
20. Pook, P.C.K., Brugger, F., Hawkins, N.S., Clark, K.C., Watkins, J.C., Evans, R.H., 1993. A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro. British Journal of Pharmacology 108, 179.
21. Schiffer, H.H., Swanson, G.T., Heinemann, S.F., 1997. Rat GluR7 and a carboxy-terminal splice variant, GluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate. Neuron 19, 1141-1146.
22. Schoepp, D.D., Lodge, D., Bleakman, D., et al., 1995. In-vitro and in-vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2H)-tetrazole-5-yl)ethyl]decahydro-isoquinoline-3-carboxylic acid. Neuropharmacology 34, 1159-1168.
23. Sløk, F.A., Ebert, B., Lang, Y., Krogsgaard-Larsen, P., Lenz, S. M., Madsen, U., 1997. Excitatory amino-acid receptor agonists. Synthesis and pharmacology of analogues of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid. European Journal of Medicinal Chemistry 32, 329-338.
24. Thomas, N.K., Clayton, P., Jane, D.E., 1997. Dicarboxyphenylglycines as selective antagonists of AMPA-induced depolarisations in neonatal rat motoneurones. European Journal of Pharmacology 338, 111-116.
25. Thompson, G.A., Jane, D.E., Watkins, J.C., 1995. Depolarising effects of certain derivatives of (S)-willardiine upon in vitro neonatal rat dorsal roots. British Journal of Pharmacology Proceedings Supplement 117, 331P.
26. Vignes, M., Bleakman, D., Lodge, D., Collingridge, G.L., 1997. The synaptic activation of the GluR5 subtype of kainate receptor in the area CA3 of the rat hippocampus. Neuropharmacology 36, 1477-1481.
27. Watkins, J.C., Krogsgaard-Larsen, P., Honoré, T., 1990. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends in Pharmacological Science 11, 25-33.
28. Wong, L.A., Mayer, M.L., Jane, D.E., Watkins, J.C., 1994. Willardiines differentiate agonist binding sites for kainate-versus AMPA-preferring glutamate receptors in DRG and hippocampal neurones. Journal of Neuroscience 14, 3881-3897.
29. Zeman, S., Lodge, D., 1992. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal-cord in vitro. British Journal of Pharmacoogy 106, 367-372.